L-DOS-47

N/A

Report date: 2025/05/15 20:00:08

Base Information

Drug NameL-DOS-47

Drug Alias NameL-DOS-47

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-CEACAM6

TargetsCarcinoembryonic antigen related cell adhesion molecule 6

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsAdenocarcinoma of Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUkrainePoland

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesHelix Biopharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHelix Biopharma Co

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsAdenocarcinoma of Lung

Other Information

ATC CodeN/A